Sandoz Prepares For European Natalizumab Launch As Approval Arrives

Company Offers Indications Of Launch Timing For Tyruko Biosimilar Rival To Tysabri

Europe by night, seen from space
Sandoz is getting ready to launch natalizumab in Europe • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products